Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody‐driven K/BxN serum–transfer arthritis

Wiley - Tập 58 Số 5 - Trang 1354-1365 - 2008
Mei Chen1, Éric Boilard, Peter A. Nigrović, Patsy Clark, Daigen Xu, Garret A. FitzGerald, Laurent Audoly, David M. Lee
1Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA

Tóm tắt

AbstractObjectiveProstaglandins (PGs) are found in high levels in the synovial fluid of patients with rheumatoid arthritis, and nonsteroidal blockade of these bioactive lipids plays a role in patient care. The aim of this study was to explore the relative contribution of cyclooxygenase (COX) isoforms and PG species in the autoantibody‐driven K/BxN serum–transfer arthritis.MethodsThe prostanoid content of arthritic ankles was assessed in ankle homogenates, and the importance of this pathway was confirmed with pharmacologic blockade. The presence of COX isoforms was assessed by Western blotting and their functional contribution was compared using COX‐1−/− and COX‐2−/− mice as well as isoform‐specific inhibitors. The relative importance of PGE2 and PGI2 (prostacyclin) was determined using mice deficient in microsomal PGE synthase 1 (mPGES‐1) and in the receptors for PGI2.ResultsHigh levels of PGE2 and 6‐keto‐PGF (a stable metabolite of PGI2) were detected in arthritic joint tissues, correlating strongly with the intensity of synovitis. Pharmacologic inhibition of PG synthesis prevented arthritis and ameliorated active disease. While both COX isoforms were found in inflamed joint tissues, only COX‐1 contributed substantially to clinical disease; COX‐1−/− mice were fully resistant to disease, whereas COX‐2−/− mice remained susceptible. These findings were confirmed by isoform‐specific pharmacologic inhibition. Mice lacking mPGES‐1 (and therefore PGE2) developed arthritis normally, whereas mice incapable of responding to PGI2 exhibited a significantly attenuated arthritis course, confirming a role of PGI2 in this arthritis model.ConclusionThese findings challenge previous paradigms of distinct “housekeeping” versus inflammatory functions of the COX isoforms and highlight the potential pathogenic contribution of prostanoids synthesized via COX‐1, in particular PGI2, to inflammatory arthritis.

Từ khóa


Tài liệu tham khảo

10.1152/physrev.1999.79.4.1193

10.1016/S0090-6980(02)00029-1

10.1096/fasebj.12.12.1063

10.1016/S0024-3205(01)01407-2

10.1152/ajprenal.2001.281.1.F1

10.1074/jbc.M402594200

10.1016/0092-8674(95)90126-4

10.1172/JCI6890

10.1111/j.1749-6632.1999.tb08723.x

10.1016/S0090-6980(02)00028-X

Egg D, 1980, Prostaglandins E2 and F2α concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases, Z Rheumatol, 39, 170

10.1016/0024-3205(80)90310-0

10.1016/S0006-2952(03)00420-9

10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9

10.1073/pnas.1332766100

10.1084/jem.20051310

10.1172/JCI0215528

10.1124/jpet.106.110387

10.1016/S0092-8674(00)81989-3

10.1016/S1074-7613(00)80045-X

10.1038/ni772

10.1126/science.286.5445.1732

10.1016/0092-8674(95)90125-6

10.1126/science.1068711

10.1172/JCI200113640

10.1097/00005344-199811000-00002

Duggan DE, 1977, Identification of the biologically active form of sulindac, J Pharmacol Exp Ther, 201, 8

10.1073/pnas.95.22.13313

10.1016/j.ejphar.2007.01.008

10.1126/science.959827

10.1172/JCI112341

10.1016/0090-6980(80)90127-6

10.1016/0090-6980(80)90126-4

10.1007/BF02265118

10.1126/science.1073176

10.1074/jbc.M403106200

10.1111/j.1462-5822.2007.00901.x

Humason GL, 1967, Animal tissue techniques

10.1084/jem.20052371

10.1016/S0002-9440(10)63016-7

Shen TY, 1977, Chemical and biological studies on indomethacin, sulindac and their analogs, Adv Drug Res, 12, 90

10.1016/S0092-8674(00)81988-1

10.1016/j.clim.2006.01.016

10.5483/BMBRep.2005.38.6.633

10.1038/sj.bjp.0703624

10.1152/ajplung.00492.2005

10.1056/NEJM200108093450607

10.1172/JCI27291

10.1016/0005-2760(96)00077-X

10.1189/jlb.1003453

10.1016/S1074-7613(02)00275-3

10.1146/annurev.immunol.14.1.397

10.4049/jimmunol.169.11.6604

10.1084/jem.20052349

10.1186/ar1748

10.4049/jimmunol.170.9.4738

10.1097/01.bor.0000129664.81052.8e

10.1016/S0065-2776(04)82005-4

10.1084/jem.20030016

Hegen M, 2006, Cytosolic phospholipase A2α‐deficient mice are resistant to arthritis in the K/BxN serum transfer model, Arthritis Rheum, 54, S177

10.1189/jlb.68.6.881

Kan H, 1996, Involvement of mitogen‐activated protein kinase and translocation of cytosolic phospholipase A2 to the nuclear envelope in acetylcholine‐induced prostacyclin synthesis in rabbit coronary endothelial cells, Mol Pharmacol, 50, 1139

Young MR, 1986, Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages, Cancer Res, 46, 160

Reddy ST, 1994, Ligand‐induced prostaglandin synthesis requires expression of the TIS10/PGS‐2 prostaglandin synthase gene in murine fibroblasts and macrophages, J Biol Chem, 269, 15473, 10.1016/S0021-9258(17)40703-4

10.4049/jimmunol.166.7.4689

Chouaib S, 1985, Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down‐regulation of transferrin receptor expression, J Immunol, 135, 1172, 10.4049/jimmunol.135.2.1172

10.1189/jlb.1002483

10.1172/JCI6400

10.1016/S0002-9440(10)65230-3

10.1172/JCI117060

10.1056/NEJMe058042